MENU
+Compare
GENW
ETF ticker: NYSE ARCA
AS OF
Sep 16 closing price
Price
$12.64
Change
-$0.07 (-0.55%)

GENW stock forecast, quote, news & analysis

The investment seeks current income and long-term capital appreciation... Show more

GENW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for GENW with price predictions
Sep 26, 2025

GENW's Stochastic Oscillator is remaining in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GENW advanced for three days, in of 20 cases, the price rose further within the following month. The odds of a continued upward trend are .

GENW may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 46 cases where GENW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for GENW moved out of overbought territory on September 12, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 9 similar instances where the indicator moved out of overbought territory. In of the 9 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on September 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GENW as a result. In of 6 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GENW turned negative on September 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 5 similar instances when the indicator turned negative. In of the 5 cases the stock turned lower in the days that followed. This puts the odds of success at .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN), BP plc (NYSE:BP), Barclays PLC (NYSE:BCS), Ericsson (NASDAQ:ERIC).

Industry description

The investment seeks current income and long-term capital appreciation. Under normal market conditions, the fund will invest at least 80% of its assets plus borrowings for investment purposes in foreign equity securities that have records of paying dividends. In addition, the fund will invest in a diversified portfolio of 25 to 50 securities typically spread across many economic sectors.

Market Cap

The average market capitalization across the Genter Capital International Div ETF ETF is 89.92B. The market cap for tickers in the group ranges from 22.11B to 239.66B. NVS holds the highest valuation in this group at 239.66B. The lowest valued company is NMR at 22.11B.

High and low price notable news

The average weekly price growth across all stocks in the Genter Capital International Div ETF ETF was 0%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 14%. MBGYY experienced the highest price growth at 5%, while SNY experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the Genter Capital International Div ETF ETF was -5%. For the same stocks of the ETF, the average monthly volume growth was 12% and the average quarterly volume growth was -33%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 38
P/E Growth Rating: 42
Price Growth Rating: 49
SMR Rating: 64
Profit Risk Rating: 30
Seasonality Score: -45 (-100 ... +100)
View a ticker or compare two or three
GENW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category ForeignLargeValue

Profile
Fundamentals
Details